Cluster 5: ai-enabled · bottlenecks · discovery
Automatically detected text-similarity community. Keywords are calculated from article titles and summaries; membership is recalculated when the published corpus changes.
Where are the bottlenecks in AI-enabled drug discovery?
A Japanese essay reviewing experimental workflows, industry disclosures and clinical progress. It distinguishes experimental throughput from evidence useful for development decisions; revenue growth and individual clinical advances do not establish an AI-driven supply shortage or a causal improvement in clinical success.